Techbio startup Scripta Therapeutics emerges from stealth by announcing a $12 million seed round to upend conventional ...

Modulight Biotherapeutics has raised $12.2m in seed funding to advance its optogenetic technology being developed for neurological disorders.

InBrain Neuroelectronics has partnered with Microsoft to explore how it can advance precision neurology by applying agentic ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish ...

In recent years, a fascinating class of peptide molecules, known broadly as sleep-related peptides, has emerged as a leading ...

A team of European researchers has developed a versatile, open-source luminescence imaging instrument designed to democratize ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis and at ...

This framework enables quantitative predictions about how cellular systems convert frequency-encoded signals into precise ...

This week in Pedersen’s POV, MD+DI Senior Editor Amanda Pedersen urges the medtech industry to follow Medtronic’s example for ...

Transposable elements play a significant role in regulating gene expression and genome architecture, influencing development, ...

New live-cell imaging data show that Telomir-1 markedly lowers intracellular iron levels at submicromolar concentrations in ...

Preclinical data highlight that PKM2 modulation inhibits several important mechanisms underlying atopic dermatitis ...